Evidence-Based Reviews

Telepsychiatry: What you need to know

Author and Disclosure Information

 

References

In a review of 452 telepsychiatry studies, Hubley et al20 focused on satisfaction, reliability, treatment outcomes, implementation outcomes, cost effectiveness, and legal issues. They concluded that patients and clinicians are generally satisfied with telepsychiatry services. Interestingly, clinicians expressed more concerns about the potential adverse effects of telepsychiatry on therapeutic rapport. Hubley et al20 found no published reports of adverse events associated with telepsychiatry use.

In a study of school-based telepsychiatry in an urban setting, Mayworm et al21 found that patients were highly satisfied with both in-person and telepsychiatry services, and there were no significant differences in preference. This study also found that telepsychiatry services were more time-efficient than in-person services.

A study of using telepsychiatry to treat unipolar depression found that patient satisfaction scores improved with increasing number of video-based sessions, and were similar among all age groups.22 An analysis of this study found that total satisfaction scores were higher for patients than for clinicians.23

In a study of satisfaction with telepsychiatry among community-dwelling older veterans, 90% of participants reported liking or even preferring telepsychiatry, even though the experience was novel for most of them.24

As always, patients’ preferences need to be kept in mind when considering what services can and should be provided via telepsychiatry, because not all patients will find it acceptable. For example, in a study of veterans’ attitudes toward treatment via telepsychiatry, Goetter et al25 found that interest was mixed. Twenty-six percent of patients were “not at all comfortable,” while 13% were “extremely comfortable” using telepsychiatry from home. Notably, 33% indicated a clear preference for telepsychiatry compared to in-person mental health visits.

Continue to: Legal aspects of telepsychiatry

Pages

Recommended Reading

Out of the pipeline: Remdesivir
Covid ICYMI
Today’s top news highlights: ACE inhibitors in COVID patients, fewer AMI admissions, and more
Covid ICYMI
Patient-focused precautions, testing help blunt pandemic effects on heme-onc unit
Covid ICYMI
Neuropsychiatric manifestations of COVID-19
Covid ICYMI
Life during COVID-19: A pandemic of silence
Covid ICYMI
Telepsychiatry during COVID-19: Understanding the rules
Covid ICYMI
Armchair epidemiology
Covid ICYMI
Remdesivir shortens COVID-19 time to recovery in published study
Covid ICYMI
Changes in patient behavior during COVID-19: What I’ve observed
Covid ICYMI
Convalescent plasma: ‘Flavor of the month’ or valid COVID-19 treatment?
Covid ICYMI